ATHENEX, INC.
Profile
Company Names
ATHENEX, INC.
KINEX PHARMACEUTICALS, INC.
KINEX PHARMACEUTICALS LLC
Addresses
1001 MAIN STREET, SUITE 600, BUFFALO, NY 14203
1001 MAIN STREET, SUITE 600, BUFFALO, NY 14203
701 ELLICOTT STREET, BUFFALO, NY 14203
Phone Numbers
(716) 427-2950
716-898-8625
716-881-8972
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS, BIOTECHNOLOGY, OTHER TECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$414,819,567.00
Number of Funding Rounds:
12
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
12
2019-12-09
$60,369,975.00
$60,369,975.00
$0.00
Equity
11
2019-05-03
$100,000,000.00
$100,000,000.00
$0.00
Equity
10
2018-06-29
$50,000,000.00
$50,000,000.00
$0.00
Equity
9
2017-04-19
$20,000,000.00
$20,000,000.00
$0.00
Debt
8
2016-09-23
$37,900,000.00
$50,000,000.00
$12,100,000.00
Debt
7
2015-04-08
$48,099,980.00
$62,799,990.00
$14,700,010.00
Equity
6
2015-04-04
$10,000,016.00
$10,000,016.00
$0.00
Equity
5
2015-03-26
$74,399,996.00
INDEFINITE
INDEFINITE
Equity
4
2013-12-12
$300,000.00
$40,000,000.00
$39,700,000.00
Equity
3
2012-07-30
$5,000,000.00
$40,000,000.00
$35,000,000.00
Equity
2
2011-04-19
$4,674,600.00
$5,000,000.00
$325,400.00
Equity
1
2009-12-30
$4,075,000.00
$6,000,000.00
$1,925,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
FLINT
BESECKER
EXECUTIVE OFFICER, DIRECTOR
CHARLES
LANNON
DIRECTOR
JOHNSON
LAU
EXECUTIVE OFFICER, DIRECTOR
MICHAEL
MURPHY
DIRECTOR
GLEICHEN RESOURCES LTD.
| NEXUS ENERGYHOMES, INC.
| TMG ENERGY CORP
| DIAMOND FOODS INC
| TOREX GOLD RESOURCES INC.
| 3D VISION SYSTEMS LLC
| NATIONAL GENERAL HOLDINGS CORP.
| HOLY MOUNTAIN BREWING CO
| AMERICAN HOTEL INCOME PROPERTIES REIT INC.
| STACKIQ, INC.
| KINEX PHARMACEUTICALS, INC.
| DISTRIBU.TD, INC.
| TRANSEASTERN POWER TRUST
| SUN CLINICAL LABORATORY, LLC - SERIES 4
| SUN CLINICAL LABORATORY, LLC - SERIES 3
| SUN CLINICAL LABORATORY, LLC - SERIES 1
| SUN CLINICAL LABORATORY, LLC - SERIES 7
| SUN CLINICAL LABORATORY, LLC - SERIES 5
| SUN CLINICAL LABORATORY, LLC - SERIES 10
| SUN CLINICAL LABORATORY, LLC - SERIES 8
| SUN CLINICAL LABORATORY, LLC - SERIES 9
| SUN CLINICAL LABORATORY, LLC - SERIES 14
| PROCTORFREE, INC.
| SUN CLINICAL LABORATORY, LLC - SERIES 15
| ROSECLIFF VENTURE PARTNERS, LP
| AHTOVATION, INC.
| ADVANTAGE ADVISERS XANTHUS FUND, L.L.C.
| AKONNI BIOSYSTEMS INC
| SUN CLINICAL LABORATORY, LLC - SERIES 29
| ALTERNATE HEALTH CORP.
| ROSECLIFF VENTURE PARTNERS II, LP
| ASSABET VALLEY BANCORP
| AMPLE HILLS HOLDINGS, INC.
| POST.BID.SHIP., INC.
| PROPHET ADVANTAGE PARTNERS LP
| ETHOS GOLD CORP.
| TENEO PARTNERS, LP
| ROSECLIFF CREDIT OPPORTUNITY FUND I, L.P.
| TORTOISE, INC.
| QUISITIVE TECHNOLOGY SOLUTIONS, INC.
| PROSPECTOR METALS CORP.
| BATTERY METALS STREAMING CORP.
| ANTHEM SPORTS + ENTERTAINMENT INC.
| MICROSHARE, INC.
| ANOKIWAVE, INC.
| ROSECLIFF FRONTIER TECHNOLOGIES FUND I, L.P.
| AQUILA HARTLAND HOLDINGS, LLC
| BOOSTLY, INC.
| SOUTH PACIFIC METALS CORP.
| ARA LABS INC.
| NEXT GENERATION SPV 1 LLC
| NEXT GENERATION SPV 2 LLC
| NEXT GENERATION SPV 3 LLC
| WPSL PRO, LLC
| ROSECLIFF NEXT GENERATION LLC - SERIES RSAI ACCESSS-1
| ROSECLIFF NEXT GENERATION LLC - SERIES P ACCESS
| ROSECLIFF NEXT GENERATION LLC - SERIES CBIO ACCESS -1
| ROSECLIFF NEXT GENERATION LLC - SERIES PVTR ACCESS
SIMON
PEDDER
EXECUTIVE OFFICER
JEAN-PIERRE
SOMMADOSSI
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-12-09
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
$25,000,001 - $100,000,000
Equity
2019-05-03
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2018-06-29
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2017-04-19
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
